<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE STATEMENT OF OPERATIONS AND BALANCE SHEET OF ALLERGAN SPECIALTY THERAPEUTICS, INC. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> APR-01-1998 <PERIOD-END> JUN-30-1998 <CASH> 72 <SECURITIES> 179,894 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 183,573 <PP&E> 0 <DEPRECIATION> 0 <TOTAL-ASSETS> 183,573 <CURRENT-LIABILITIES> 4,373 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 34 <OTHER-SE> 179,166 <TOTAL-LIABILITY-AND-EQUITY> 183,573 <SALES> 0 <TOTAL-REVENUES> 2,791 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 8,006 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (5,215) <INCOME-TAX> 922 <INCOME-CONTINUING> (6,137) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (6,137) <EPS-PRIMARY> (1.87) <EPS-DILUTED> (1.87)